Last reviewed · How we verify
NCT06822920: DM&DMO
Post-Market Clinical Investigation Plan - Collagen Dura Membranes (DM & DMO)
trial in Repair of Dura Mater in 110 participants. Currently enrolling.
30 September 2025
Quick facts
| Lead sponsor | Collagen Matrix |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 110 |
| Start date | 3 January 2025 |
| Primary completion | 30 September 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across United States |
Conditions studied
- Repair of Dura Mater — all drugs for Repair of Dura Mater →
Sponsor
Collagen Matrix
Who can join
18 and older, any sex, with Repair of Dura Mater. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Monitoring the Use of Collagen Dura Membrane in the Post-market phase
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06822920
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Repair of Dura Mater
Currently open trials in the same condition.
- NCT06802133 — Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) · recruiting
Other Collagen Matrix trials
Trials by the same sponsor.
- NCT06802133 — Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) · recruiting
- NCT05371535 — A Clinical Trial to Evaluate the Safety and Effectiveness of MatrixOssTM Bone Graft · NA · unknown
- NCT04851847 — A Clinical Trial to Evaluate the Safety and Effectiveness of Resorbable Collagen Membrane - MatrixflexTM · NA · unknown
- NCT04775537 — OssiMend BA in Posterolateral Instrumented Lumbar Fusion · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06822920 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Collagen Matrix
- Last refreshed: 12 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06822920.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing